Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Has Consensus Price Target of $21.50

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have been given an average rating of “Moderate Buy” by the fourteen analysts that are covering the stock, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $21.50.

A number of equities research analysts have recently weighed in on SBRA shares. Mizuho set a $21.00 price target on Sabra Healthcare REIT in a report on Monday, August 31st. UBS Group dropped their price objective on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 13th. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Robert W. Baird raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Monday, August 31st. Finally, Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th.

Insiders Place Their Bets

In other news, CEO Richard Matros sold 200,000 shares of the business’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the transaction, the chief executive officer owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. The trade was a 10.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of hedge funds have recently made changes to their positions in SBRA. Principal Financial Group Inc. grew its stake in shares of Sabra Healthcare REIT by 0.4% in the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock worth $481,755,000 after purchasing an additional 98,770 shares in the last quarter. Lasalle Investment Management Securities LLC lifted its position in Sabra Healthcare REIT by 8.2% in the first quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust’s stock worth $73,547,000 after purchasing an additional 290,405 shares during the period. Dimensional Fund Advisors LP lifted its position in Sabra Healthcare REIT by 7.8% in the first quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock worth $71,640,000 after purchasing an additional 269,793 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its stake in Sabra Healthcare REIT by 6.8% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock valued at $61,701,000 after purchasing an additional 203,226 shares in the last quarter. Finally, Rush Island Management LP bought a new position in Sabra Healthcare REIT during the 1st quarter valued at $30,735,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Up 3.7%

Shares of NASDAQ SBRA opened at $19.60 on Tuesday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $22.77. The stock’s 50-day simple moving average is $19.98 and its 200-day simple moving average is $20.06. The firm has a market cap of $5.01 billion, a price-to-earnings ratio of 75.39, a PEG ratio of 1.43 and a beta of 0.63.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The business had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The company’s revenue for the quarter was up 24.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.38 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 461.54%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.